|
But this indicates lack of incentives to reduce healthcare costs by optimisation. If AI can do something well enough , and AI + humans surpass humans leading to costs reductions/ increased throughput this should be reflected in the workflows. I feel that human processes have inertia and for lack of a better word, gatekeepers feel that new, novel approaches should be adopted slowly and which is why we are not seeing the impact, yet. Once a country with the right incentive structure (e.g. China ) can show that it can outperform and help improve the overall experience I am sure things will change. While 10 years progress is a lot in ML, AI , in more traditional fields it probably is a blip to change this institutional inertia which will change generation by generation. All that is needed is an external actor to take the risk and show a step change improvement. Having experienced how healthcare in US I feel people are only scared to take on bold challenges |
From the article